Oncology: State-of-the-Art Researches in Poland
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 29 November 2024 | Viewed by 2376
Special Issue Editors
Interests: bladder cancer; genetic markers; heterogeneity of cancers; liquid biopsy; NGS; artificial intelligence
Special Issue Information
Dear Colleagues,
In recent decades, significant progress in the field of cancer therapy has been achieved. Despite this, tumor response to treatment is still suboptimal. This is partly due to the failure to identify subgroups of patients who may benefit most from a particular therapy. Therefore, efforts to identify such subgroups and to search for new markers are still challenging.
In this Special Issue, we aim to showcase state-of-the-art research in oncology in Poland. We invite submissions looking at all kinds of research covering all cancer types and stages, from basic laboratory research to translational and clinical research, including cohort studies, randomized controlled trials, and epidemiological studies. Submitting a paper to this Special Issue of Cancers is a good opportunity to contribute to the international visibility of the important efforts carried out by large and small cancer research groups throughout the different Polish research centers, universities, and other academic and research institutions.
Dr. Edyta Marta Borkowska
Dr. Piotr Potemski
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- oncology
- biomarkers
- personalized treatment
- Poland
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.